5-Fluorocytosine (5-FC) CAS 2022-85-7 Munditia ≥99.5%

Description:

Nomen chemicum: 5-Fluorocytosinum;5-FC

CAS: 2022-85-7

Aspectus: Albus vel Fere Albus Crystallinus Pulvis

Puritas: ≥99.5% (HPLC)

Capecitabin (CAS: 154361-50-9) & Emtricitabin (CAS: 143491-57-0)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Commercial Supple Capecitabine Related Intermedia:
5-Fluorocytosine CAS: 2022-85-7
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidinis CAS: 161599-46-8
1,2,3 Tri-O-acetyl-5-deoxy-β-D-ribofuranosum CAS: 62211-93-2
Capecitabine CAS: 154361-50-9 

Chemical Properties:

Nomen 5-Fluorocytosine
Synonyma 5-FC;Triticum aestivum;4-Amino-5-fluoro-2-hydroxypyrimidine
CAS Number 2022-85-7
CATTUS Number RF-PI175
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C4H4FN3O
M. Pondus 129.09
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba aut fere alba Crystallina pulveris
Lepidium sativum IR Effusio spectri exempli ultrarubri concordare debet cum spectro vexilli
Puritas / Analysis Methodus ≥99.5% (HPLC)
Cytosine ≤0.10%
Alia individua immunditia ≤0.10%
Solubilitas Parce solutum in aqua;Solutum in Sin;Paractically in Chloroform et in Ether
Damnum in Siccatio ≤1.5% w/w (ante 105℃ 4 h)
Residere in Ignition ≤0.10% w/w
Metalla gravia (Pb) ≤20ppm
Fluorinc ≤500ppm
5-Fluorouracil ≤0.10%
Assay 98.5% ~ 101.0% (calculata in exaruit basis)
Test Standard Enterprise Standard
Consuetudinem Capecitabine & Emtricitabine Intermediate;Pharmaceutical intermedia
flumine Product Cytosine CAS: 71-30-7

5-Fluorocytosine (5-FC) CAS: 2022-85-7 Analysis Methodus
Aspectus-White vel Fere Alba Crystallina pulveris
Damnum in siccitate in 105 pro 4 horis: non plus quam 1.50% sui ponderis amittit.
Residere in Ignitione non plus quam 0,1%.
Metalla gravia-non plus quam 0.02%.
Fluoride-Misce 70 mL solutione potassii chloridi recenter praeparati cum solutione chloridi isopropyl 30 mL, electrodam liquido supernatante imple, et permittit electronicum manere in mixtione non minus quam 2 horis ante utendum, vel potius pernoctare.
Cum mensuris capiendis, solutionem 150-mL compensatoris transferas, et electrodes immergas.Insert polytefico-libratum in compensatorem moventem, poculum in movente magnetico cacumine insulato habentem, movere permitte, donec aequilibrium attingatur (circiter 1 ad 2 minuta).Electrodes inter mensuras eluam et exsiccant, cavens ne crystallum in electrode specifico scalpturo.
Metire potentialem uniuscuiusque Parasceves Latin, et retrahitur fluoride machinatur, in mg per 100 mL, versus potentialem, in mV, in charta semilogarithmica.Metire potentialem Praeparationis Test, et ex norma curva determinant intentionem fluoride, in mg per 100 mL.Recipis fluoride in portione Flucytosini sumpta formula:
C / 10
in qua C est concentratio fluoride, in mg per 100 mL, a curva mensura: non plus quam 0.05% fluoride inuenitur.
Fluorouracil-Dissolve 250 mg in 10 mL mixtionis acidi glacialis et aquae (4:1).Applica 20 µL huius solutionis ad laminam chromatographicam tenui-straminis obductis cum strato chromatographico silicae gel mixtionis 0,5-mm.Ad eandem laminam applicamus 20 µL, in 10-µL incrementis 0.025 mg per mL solutionem USP Fluorouracil RS in mixtione acidi acetici et aquae glacialis (4, 1).Chromatogrammum evolvere in mixto acido chloroformi et glaciali acetico (13:7) donec frontem solvens non minus quam 14 cm ab origine movit.Remove bracteam e conclavi elaborando, et solvendo evaporare permitte.Maculas in lamella collocare observando sub radiis brevibus necem UV: macula quaelibet e solutione sub experimento non maior est magnitudine et intensione quam macula in respectivo RF per solutionem Latinam productam, respondens non plus quam 0.1% of. fluorouracil.
Assay-Plac circa 400 mg Flucytosini accurate perpensa, in 250 mL compensatur, adde 150 mL mixturam 2 voluminum acidi glacialis acetici et 1 voluminis anhydridis acetici, et solve, si opus est, leniter calefaciens.Titrate potentiometrice cum acido perchlorico 0.1 N VS, systemate electrode vitri calomel utens.Fac blank determinationes, et emendas quamlibet necessarias.Quodlibet mL ex 0.1 N acidi perchlorici aequipollet 12.91 mg C4H4FN3O.Flucytosina non minus quam 98.5 centesimas continet et non plus quam 101.0 centesimas C4H4FN3O, fundamento siccato computata.

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum 5-Fluorocytosini CAS: 2022-85-7 (Fluorocytosine; 5-FC) cum qualitate, late in synthesi organica adhibita, synthesis intermediorum pharmaceuticae et pharmaceuticae Ingredientis activae. (API) synthesis.5-Fluorocytosine (CAS: 2022-85-7) est medium Capecitabinum (CAS: 154361-50-9) et Emtricitabinum (CAS: 143491-57-0).

5-Fluorocytosinum est analogon fluorinatum cytosini.5-FC approbatur ab US Cibus et Drug Administration (FDA) ut agens antifungalum adhibitum pro tractatione Candidae et Cryptococci.Nuper cum evolutione therapiae gene, 5-FC introducta est ut prodrug in compositione cum gene deaminationis cytosinae suicidii.

Epistulam tuam hic scribe et mitte nobis